STOCK TITAN
  1. Home
  2. Sec-filings
  3. CI
  4. [Form 4] Cigna Group Insider Trading Activity

Cigna (CI) CFO granted options and restricted stock with tax share withholding

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cigna Group EVP and CFO Ann M. Dennison reported equity compensation changes involving company stock. She received an award of 8,066 employee stock options with an exercise price of $0.0000, which vest in three equal annual installments beginning on March 1, 2027. She was also granted 5,234 shares of common stock as restricted shares that vest in three equal annual installments beginning on March 1, 2027. To satisfy tax obligations upon the vesting of restricted shares, 409 shares of common stock were disposed of at $287.55 per share through share withholding, leaving her with 7,745 common shares held directly.

Positive

  • None.

Negative

  • None.
Insider DENNISON ANN M
Role EVP, CFO
Type Security Shares Price Value
Grant/Award Employee Stock Option (Right to Buy) 8,066 $0.00 --
Grant/Award Common Stock, $.01 Par Value 5,234 $0.00 --
Tax Withholding Common Stock, $.01 Par Value 409 $287.55 $118K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 8,066 shares (Direct); Common Stock, $.01 Par Value — 8,154 shares (Direct)
Footnotes (1)
  1. These restricted shares vest in three equal annual installments beginning March 1, 2027. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. This option vests in three equal annual installments beginning March 1, 2027.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
DENNISON ANN M
(Last) (First) (Middle)
900 COTTAGE GROVE ROAD
(Street)
BLOOMFIELD CT 06002
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cigna Group [ CI ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, CFO
3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $.01 Par Value 02/27/2026 A 5,234(1) A $0 8,154 D
Common Stock, $.01 Par Value 02/27/2026 F 409(2) D $287.55 7,745 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $287.5475 02/27/2026 A 8,066 03/01/2027(3) 02/27/2036 Common Stock, $.01 Par Value 8,066 $0 8,066 D
Explanation of Responses:
1. These restricted shares vest in three equal annual installments beginning March 1, 2027.
2. Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
3. This option vests in three equal annual installments beginning March 1, 2027.
Remarks:
Tyler Gratton, attorney-in-fact 03/02/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What equity awards did Cigna (CI) CFO Ann Dennison receive?

Cigna’s CFO Ann Dennison received 8,066 employee stock options and 5,234 restricted common shares. Both the options and restricted shares vest in three equal annual installments starting March 1, 2027, aligning her compensation more closely with the company’s long-term performance.

How do the new Cigna (CI) stock options for the CFO vest?

The 8,066 stock options granted to Cigna CFO Ann Dennison vest in three equal annual installments beginning March 1, 2027. This phased vesting schedule encourages longer-term retention and links a portion of her compensation to future share price performance.

What are the terms of the restricted stock granted to Cigna (CI) CFO?

Ann Dennison was granted 5,234 restricted shares of Cigna common stock. These restricted shares vest in three equal annual installments starting March 1, 2027, providing time-based equity compensation that depends on continued service over several years.

Why were 409 Cigna (CI) shares disposed of in this Form 4 filing?

The Form 4 shows 409 Cigna common shares disposed of to satisfy tax obligations upon vesting of restricted shares. The shares were withheld at a price of $287.55 per share, representing a tax-withholding disposition rather than an open-market sale.

How many Cigna (CI) common shares does the CFO hold after these transactions?

After the reported transactions, Ann Dennison directly holds 7,745 Cigna common shares. This figure reflects the newly granted restricted stock and the 409 shares withheld to cover tax obligations related to restricted share vesting on the reported date.

Are the Cigna (CI) CFO’s new equity awards immediately exercisable or vested?

No, the new awards are not fully immediate. Both the 8,066 stock options and 5,234 restricted shares vest in three equal annual installments beginning March 1, 2027, meaning full vesting occurs only after several years of continued service.